Mee-Hyun Lee[Author] - Search Results

Year	Number of Results
2004	1
2005	1
2009	3
2010	1
2011	2
2012	6
2013	13
2014	13
2015	5
2016	6
2017	13
2018	13
2019	17
2020	17
2021	15
2022	8
2023	13
2024	3

1

Song M, Bode AM, Dong Z, Lee MH. Song M, et al. Among authors: lee mh. Cancer Res. 2019 Mar 15;79(6):1019-1031. doi: 10.1158/0008-5472.CAN-18-2738. Epub 2019 Feb 26. Cancer Res. 2019. PMID: 30808672 Review.

2

Editorial: Characterizing the uncharacterized human proteins.

Xu YM, Lee MH, Wong CM, Lau ATY. Xu YM, et al. Among authors: lee mh. Front Genet. 2023 May 4;14:1203691. doi: 10.3389/fgene.2023.1203691. eCollection 2023. Front Genet. 2023. PMID: 37234873 Free PMC article. No abstract available.

3

Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer.

Tian X, Wang R, Gu T, Ma F, Laster KV, Li X, Liu K, Lee MH, Dong Z. Tian X, et al. Among authors: lee mh. Mol Cancer. 2022 Oct 6;21(1):193. doi: 10.1186/s12943-022-01662-1. Mol Cancer. 2022. PMID: 36203195 Free PMC article.

4

A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.

Wang Y, Gu T, Tian X, Li W, Zhao R, Yang W, Gao Q, Li T, Shim JH, Zhang C, Liu K, Lee MH. Wang Y, et al. Among authors: lee mh. Front Immunol. 2021 May 14;12:654463. doi: 10.3389/fimmu.2021.654463. eCollection 2021. Front Immunol. 2021. PMID: 34054817 Free PMC article.

5

NUMA1 modulates apoptosis of esophageal squamous cell carcinoma cells through regulating ASK1-JNK signaling pathway.

Yin S, Zhao S, Li J, Liu K, Ma X, Zhang Z, Wang R, Tian J, Liu F, Song Y, Song M, Zhao R, Yang R, Lee MH, Dong Z. Yin S, et al. Among authors: lee mh. Cell Mol Life Sci. 2023 Jul 18;80(8):211. doi: 10.1007/s00018-023-04854-0. Cell Mol Life Sci. 2023. PMID: 37462735

6

Targeting ROCK/LIMK/cofilin signaling pathway in cancer.

Lee MH, Kundu JK, Chae JI, Shim JH. Lee MH, et al. Arch Pharm Res. 2019 Jun;42(6):481-491. doi: 10.1007/s12272-019-01153-w. Epub 2019 Apr 27. Arch Pharm Res. 2019. PMID: 31030376 Review.

7

Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint.

Gu T, Tian X, Wang Y, Yang W, Li W, Song M, Zhao R, Wang M, Gao Q, Li T, Zhang C, Kundu JK, Liu K, Dong Z, Lee MH. Gu T, et al. Among authors: lee mh. Front Immunol. 2023 May 2;14:1145028. doi: 10.3389/fimmu.2023.1145028. eCollection 2023. Front Immunol. 2023. PMID: 37205112 Free PMC article.

8

Preclinical activities of Cassia tora Linn against aging-related diseases.

Hwang SY, Na CS, Moon BC, Shim JH, Lee MH. Hwang SY, et al. Among authors: lee mh. Expert Rev Mol Med. 2022 Oct 25;24:e43. doi: 10.1017/erm.2022.33. Expert Rev Mol Med. 2022. PMID: 36281483 Review.

9

PIM Kinase as an Executional Target in Cancer.

Zhang X, Song M, Kundu JK, Lee MH, Liu ZZ. Zhang X, et al. Among authors: lee mh. J Cancer Prev. 2018 Sep;23(3):109-116. doi: 10.15430/JCP.2018.23.3.109. Epub 2018 Sep 30. J Cancer Prev. 2018. PMID: 30370255 Free PMC article. Review.

10

eEF1A2 as a putative oncogene.

Lee MH, Surh YJ. Lee MH, et al. Ann N Y Acad Sci. 2009 Aug;1171:87-93. doi: 10.1111/j.1749-6632.2009.04909.x. Ann N Y Acad Sci. 2009. PMID: 19723040 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year